Show
Sort by
-
Identifying and validating DNA methylation biomarkers: the example of neuroblastoma
-
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
-
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
-
The MYCN driven murine and human neuroblastoma methylome and dynamic regulation of chromatin regulators as a guide for epigenetic therapy
-
Genome wide expression, mutation and methylation analysis validates three new mouse models for neuroblastoma targeting MYCN, ALK and LIN28B for pre-clinical studies
-
- Journal Article
- A1
- open access
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma
-
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
-
Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastoma
-
Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas
-
- Journal Article
- A1
- open access
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.